Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.118.310882
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)